These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1128 related articles for article (PubMed ID: 225625)

  • 1. The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells.
    Fuller BB; Viskochil DH
    Life Sci; 1979 Jun; 24(26):2405-15. PubMed ID: 225625
    [No Abstract]   [Full Text] [Related]  

  • 2. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB; Lebowitz J
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine responsiveness in human melanocytes and melanoma cells in culture.
    Fuller BB; Meyskens FL
    J Natl Cancer Inst; 1981 May; 66(5):799-802. PubMed ID: 6262556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tyrosinase activity and protein synthesis in melanoma cells by calcium ionophore A23187.
    Fuller BB
    Pigment Cell Res; 1987; 1(3):176-80. PubMed ID: 2854256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopic and cytochemical observations of theophylline and melanocyte-stimulating hormone effects on melanoma cells in culture.
    Hu F; Mah K; Teramura DJ
    Cancer Res; 1982 Jul; 42(7):2786-91. PubMed ID: 6805946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSH and melanoma cells.
    Lerner AB; Varga JM
    Front Horm Res; 1977; 4():126-8. PubMed ID: 207590
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
    Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of melanogenesis in mouse melanoma cells of varying metastatic potential.
    Niles RM; Makarski JS
    J Natl Cancer Inst; 1978 Aug; 61(2):523-6. PubMed ID: 210294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones.
    Wong G; Pawelek J
    Nat New Biol; 1973 Feb; 241(111):213-5. PubMed ID: 4349438
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulation by melanocyte stimulating hormone and dibutyryl adenosine 3'5'-cyclic monophosphate of DNA synthesis in human melanocytes in vitro.
    Kitano Y
    Arch Dermatol Res (1975); 1976 Nov; 257(1):47-52. PubMed ID: 188388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of receptors for beta-melanocyte stimulating hormone in Cloudman melanoma cells is increased by dibutyryl adenosine 3':5'-cyclic monophosphate or cholera toxin.
    DiPasquale A; McGuire J; Varga JM
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):601-5. PubMed ID: 191818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of melanogenesis in vitro in the epidermal melanoblasts of newborn mouse skin by MSH.
    Hirobe T; Takeuchi T
    In Vitro; 1977 May; 13(5):311-5. PubMed ID: 194827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on melanotropin (MSH) receptors of melanophores and melanoma cells.
    Eberle AN
    Biochem Soc Trans; 1981 Feb; 9(1):37-9. PubMed ID: 6260553
    [No Abstract]   [Full Text] [Related]  

  • 15. alpha-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line.
    Legros F; Coel J; Doyen A; Hanson P; Van Tieghem N; Vercammen-Grandjean A; Fruhling J; Lejeune FJ
    Cancer Res; 1981 Apr; 41(4):1539-44. PubMed ID: 6260342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinase isoenzymes in mammalian melanocytes. 2. Differential activation by alpha-melanocyte-stimulating hormone.
    Valverde P; Garcia-Borron JC; Jimenez-Cervantes C; Solano F; Lozano JA
    Eur J Biochem; 1993 Oct; 217(2):541-8. PubMed ID: 7901010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinase maturation and pigment expression in B16 melanoma: relation to theophylline treatment and intracellular cyclic AMP.
    White R; Hanson GC; Hu Funan
    J Cell Physiol; 1979 Jun; 99(3):441-50. PubMed ID: 222787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells.
    Wong G; Pawelek J
    Nature; 1975 Jun; 255(5510):644-6. PubMed ID: 806022
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of 5-bromodeoxyuridine on cyclic AMP levels and cytoskeletal organization in malignant melanoma cells.
    Giotta GJ; Brunson KW; Lotan R
    Cell Biol Int Rep; 1980 Jan; 4(1):105-16. PubMed ID: 6248251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system.
    Körner A; Pawelek J
    Nature; 1977 Jun; 267(5610):444-7. PubMed ID: 17836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 57.